Access to Therapeutics and Vaccines in Times of Health Pandemics: How Exclusivity Rights Can Affect Such Access and What We Can Do About It
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Access to Therapeutics and Vaccines in Times of Health Pandemics: How Exclusivity Rights Can Affect Such Access and What We Can Do About It. / Bostyn, Sven.
In: Intellectual Property Quarterly, Vol. 2020, No. 4, 2020, p. 227-270.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Bostyn, S 2020, 'Access to Therapeutics and Vaccines in Times of Health Pandemics: How Exclusivity Rights Can Affect Such Access and What We Can Do About It', Intellectual Property Quarterly, vol. 2020, no. 4, pp. 227-270. <https://uk.westlaw.com/Document/IC5A4B8E0248111EB84E3AFDEA08E8491/View/FullText.html>
APA
Bostyn, S. (2020). Access to Therapeutics and Vaccines in Times of Health Pandemics: How Exclusivity Rights Can Affect Such Access and What We Can Do About It. Intellectual Property Quarterly, 2020(4), 227-270. https://uk.westlaw.com/Document/IC5A4B8E0248111EB84E3AFDEA08E8491/View/FullText.html
Vancouver
Bostyn S. Access to Therapeutics and Vaccines in Times of Health Pandemics: How Exclusivity Rights Can Affect Such Access and What We Can Do About It. Intellectual Property Quarterly. 2020;2020(4):227-270.
Author
Bibtex
@article{fb6abff76dda4678b19cd54730e3ed15,
title = "Access to Therapeutics and Vaccines in Times of Health Pandemics: How Exclusivity Rights Can Affect Such Access and What We Can Do About It",
author = "Sven Bostyn",
year = "2020",
language = "English",
volume = "2020",
pages = "227--270",
journal = "Intellectual Property Quarterly",
issn = "1364-906X",
publisher = "Sweet & Maxwell Ltd.",
number = "4",
}
RIS
TY - JOUR
T1 - Access to Therapeutics and Vaccines in Times of Health Pandemics: How Exclusivity Rights Can Affect Such Access and What We Can Do About It
AU - Bostyn, Sven
PY - 2020
Y1 - 2020
M3 - Journal article
VL - 2020
SP - 227
EP - 270
JO - Intellectual Property Quarterly
JF - Intellectual Property Quarterly
SN - 1364-906X
IS - 4
ER -
ID: 253653608